Cargando…
Cardiovascular and Heart Failure Management of COVID-19: The New York Experience
The COVID-19 pandemic in New York started in March 2022 and rapidly escalated in a devastating way. There were almost 3,000 deaths per million population in United States as of May 5, 2022. In addition to pulmonary manifestations, COVID-19 is associated with deleterious effects on the cardiovascular...
Autor principal: | Uriel, Nir Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440027/ http://dx.doi.org/10.1016/j.cardfail.2022.07.008 |
Ejemplares similares
-
Masque acné et COVID-19 : étude au CHU de Casablanca
por: Bennouna, Nada, et al.
Publicado: (2021) -
COVID-19 et psoriasis chez l’enfant. Données d’une cohorte internationale
por: Zitouni, Jinane, et al.
Publicado: (2021) -
PROCALCITONINA COMO BIOMARCADOR DE PNEUMONIA ASSOCIADA A VENTILAÇÃO MECÂNICA EM PACIENTES COM COVID‐19: É UMA FERRAMENTA ÚTIL NO CONTROLE DE ANTIBÓTICO?
por: Côrtes, Marina Farrel, et al.
Publicado: (2021) -
Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study
por: Aebi-Popp, Karoline, et al.
Publicado: (2014) -
Heart Failure in the COVID-19 Pandemic: Where Has All New York's Congestion Gone?
por: Barghash, Maya H., et al.
Publicado: (2020)